Invention Grant
- Patent Title: Urea derivative or pharmacologically acceptable salt thereof
-
Application No.: US16580909Application Date: 2019-09-24
-
Publication No.: US10696630B2Publication Date: 2020-06-30
- Inventor: Hiroyasu Takahashi , Yoshifumi Saito , Kosuke Tsuda , Mitsuhito Shibasaki , Kohei Ohata
- Applicant: Kyorin Pharmaceutical Co. Ltd.
- Applicant Address: JP Tokyo
- Assignee: Kyorin Pharmaceuticals Co., Ltd.
- Current Assignee: Kyorin Pharmaceuticals Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: BakerHostetler
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@522ee446
- Main IPC: C07D207/273
- IPC: C07D207/273 ; C07D403/12 ; C07D401/04 ; C07D401/12 ; C07D405/04 ; C07D405/12 ; C07D409/04 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D209/54 ; C07D405/14 ; C07D413/14 ; C07D401/06 ; C07D403/04 ; C07D409/14 ; C07D413/06 ; C07D207/22
Abstract:
Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect.The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.
Public/Granted literature
- US20200010415A1 Urea Derivative Or Pharmacologically Acceptable Salt Thereof Public/Granted day:2020-01-09
Information query
IPC分类:
